Aptose Biosciences Inc APTO
$1.71 $1.44 (45.71%) 1D
Last Updated: Apr 01, 12:00 AM·BE
Pricing for DE stocks is delayed by 24 hours
Open navigation menu
Invest
Invest on your own
We do it for you
Halal tools
Screeners
Your portfolio
Calculators
Shariah
Our certifications
Learn
Education
Get help
Pricing
Company
About Musaffa
Investors
Build with us
Is Aptose Biosciences Inc Stock Halal?
Shariah Compliance Analysis of APTO Stock
Germany Health Care Nano Cap No. As of September 2026, Aptose Biosciences Inc (APTO) is classified as NOT HALAL by Musaffa under its AAOIFI-based Shariah screening methodology. Aptose Biosciences Inc does not pass Musaffa's business and financial screening criteria.
Aptose Biosciences, Inc. is a clinical-stage oncology company, which engages in the discovery, research, and development of anti-cancer therapies. The company is headquartered in North York, Ontario and currently employs 13 full-time employees. The firm's small molecule cancer therapeutics pipeline includes products designed to provide single agent efficacy and to enhance the efficacy of other anti-cancer therapies and regimens without overlapping toxicities. Its lead clinical-stage compound Tuspetinib (TUS), is an oral kinase inhibitor that has demonstrated activity as a monotherapy and in combination therapy in patients with relapsed or refractory acute myeloid leukemia (AML) and is being developed as a frontline triplet therapy in newly diagnosed AML. Its Luxeptinib (LUX) is being developed for the treatment of patients with certain B-cell malignancies, including chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and certain non-Hodgkin’s lymphomas (NHL) who are resistant or intolerant to conventional treatments.
APTO Shariah Compliance
Screening Methodology: AAOIFI
As of September 2026, Aptose Biosciences Inc is classified as not halal.
NOT HALAL
Report Source: undefined Quarter Report
Aptose Biosciences Inc (APTO) Chart
Financial Metrics & Statements of Aptose Biosciences Inc (APTO)
FAQ's for Aptose Biosciences Inc (APTO)
- As of September 2026, Aptose Biosciences Inc APTO is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Aptose Biosciences Inc using these criteria to determine its compliance status.
- Muslim investors may consider investing in Aptose Biosciences Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Aptose Biosciences Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Aptose Biosciences Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Aptose Biosciences Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for Aptose Biosciences Inc (APTO)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
